APA (7th ed.) Citation

Butler, W., Xu, L., Zhou, Y., Cheng, Q., Hauck, J. S., He, Y., . . . Huang, J. (2023). Oncofetal protein glypican‐3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer. The Journal of pathology, 260(1), 43-55. https://doi.org/10.1002/path.6063

Chicago Style (17th ed.) Citation

Butler, William, et al. "Oncofetal Protein Glypican‐3 Is a Biomarker and Critical Regulator of Function for Neuroendocrine Cells in Prostate Cancer." The Journal of Pathology 260, no. 1 (2023): 43-55. https://doi.org/10.1002/path.6063.

MLA (9th ed.) Citation

Butler, William, et al. "Oncofetal Protein Glypican‐3 Is a Biomarker and Critical Regulator of Function for Neuroendocrine Cells in Prostate Cancer." The Journal of Pathology, vol. 260, no. 1, 2023, pp. 43-55, https://doi.org/10.1002/path.6063.